Loading clinical trials...
Loading clinical trials...
A Randomized, Open, Comparative Multicentre Trial of 3 Years Anastrozole Treatment vs. 3 Years no Treatment in Postmenopausal Patients With Breast Cancer Who Have Completed 5 Years Adjuvant Hormone Therapy.
Conditions
Interventions
Anastrozole
Locations
51
Austria
Research Site
Amstetten, Austria
Research Site
Bad Ischl, Austria
Research Site
Baden, Austria
Research Site
Bregenz, Austria
Research Site
Bruck an der Mur, Austria
Research Site
Dornbirn, Austria
Start Date
January 1, 1996
Last Updated
May 1, 2009
NCT07191730
NCT06797635
NCT06312176
NCT07003841
NCT07396766
NCT06443645
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions